nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ACE inhibition, ACE2 and angiotensin-(17) axis in kidney and cardiac inflammation and fibrosis
|
Simões e Silva, Ana Cristina |
|
2016 |
107 |
C |
p. 154-162 9 p. |
artikel |
2 |
Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms
|
Song, Yang |
|
2016 |
107 |
C |
p. 117-124 8 p. |
artikel |
3 |
Addressing the burden of epilepsy: Many unmet needs
|
Beghi, Ettore |
|
2016 |
107 |
C |
p. 79-84 6 p. |
artikel |
4 |
Anti-hypertensive property of a nickel-piperazine/NO donor in spontaneously hypertensive rats
|
Monti, Martina |
|
2016 |
107 |
C |
p. 352-359 8 p. |
artikel |
5 |
Bioresorbable vascular scaffolds: Biodegradation, drug delivery and vascular remodeling
|
Tesfamariam, Belay |
|
2016 |
107 |
C |
p. 163-171 9 p. |
artikel |
6 |
Blocking the FGF/FGFR system as a two-compartment antiangiogenic/antitumor approach in cancer therapy
|
Giacomini, Arianna |
|
2016 |
107 |
C |
p. 172-185 14 p. |
artikel |
7 |
Cannabidiol and epilepsy: Rationale and therapeutic potential
|
Leo, Antonio |
|
2016 |
107 |
C |
p. 85-92 8 p. |
artikel |
8 |
Cardiotrophin-1 therapy prevents gentamicin-induced nephrotoxicity in rats
|
Quirós, Yaremi |
|
2016 |
107 |
C |
p. 137-146 10 p. |
artikel |
9 |
Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials
|
Sahebkar, Amirhossein |
|
2016 |
107 |
C |
p. 234-242 9 p. |
artikel |
10 |
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
|
Roskoski Jr., Robert |
|
2016 |
107 |
C |
p. 249-275 27 p. |
artikel |
11 |
Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials
|
Dinca, Madalina |
|
2016 |
107 |
C |
p. 360-371 12 p. |
artikel |
12 |
Editorial Board
|
|
|
2016 |
107 |
C |
p. i- 1 p. |
artikel |
13 |
Effect of pentoxifylline on renal outcomes in chronic kidney disease patients: A systematic review and meta-analysis
|
Leporini, Christian |
|
2016 |
107 |
C |
p. 315-332 18 p. |
artikel |
14 |
Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model
|
Ma, Yinzhong |
|
2016 |
107 |
C |
p. 291-299 9 p. |
artikel |
15 |
Equol increases cerebral blood flow in rats via activation of large-conductance Ca2+-activated K+ channels in vascular smooth muscle cells
|
Yu, Wei |
|
2016 |
107 |
C |
p. 186-194 9 p. |
artikel |
16 |
Extended-Synaptotagmins (E-Syts); the extended story
|
Herdman, Chelsea |
|
2016 |
107 |
C |
p. 48-56 9 p. |
artikel |
17 |
Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer
|
Truffi, Marta |
|
2016 |
107 |
C |
p. 57-65 9 p. |
artikel |
18 |
Identification of Spongionella compounds as cyclosporine A mimics
|
Sánchez, Jon Andoni |
|
2016 |
107 |
C |
p. 407-414 8 p. |
artikel |
19 |
Long-term administration of angiotensin (17) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db/db) by reducing oxidative stress, inflammation and pathological remodeling
|
Papinska, Anna M. |
|
2016 |
107 |
C |
p. 372-380 9 p. |
artikel |
20 |
Management of genetic epilepsies: From empirical treatment to precision medicine
|
Striano, Pasquale |
|
2016 |
107 |
C |
p. 426-429 4 p. |
artikel |
21 |
Microenvironment and autophagy cross-talk: Implications in cancer therapy
|
Gomes, Luciana R. |
|
2016 |
107 |
C |
p. 300-307 8 p. |
artikel |
22 |
MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease
|
Belleville-Rolland, Tiphaine |
|
2016 |
107 |
C |
p. 381-389 9 p. |
artikel |
23 |
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis
|
Citraro, Rita |
|
2016 |
107 |
C |
p. 333-343 11 p. |
artikel |
24 |
Off-Target drug effects resulting in altered gene expression events with epigenetic and Quasi-Epigenetic origins
|
Anderson, Stephen J. |
|
2016 |
107 |
C |
p. 229-233 5 p. |
artikel |
25 |
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?
|
Del Re, M. |
|
2016 |
107 |
C |
p. 398-406 9 p. |
artikel |
26 |
Pharmacological targeting of redox regulation systems as new therapeutic approach for psychiatric disorders: A literature overview
|
Schiavone, Stefania |
|
2016 |
107 |
C |
p. 195-204 10 p. |
artikel |
27 |
Pharmacological treats for SUMO addicts
|
Licciardello, Marco P. |
|
2016 |
107 |
C |
p. 390-397 8 p. |
artikel |
28 |
Pharmacology of the cell/matrix form of adhesion
|
Meldolesi, Jacopo |
|
2016 |
107 |
C |
p. 430-436 7 p. |
artikel |
29 |
Potentiation of acid-sensing ion channel activity by peripheral group I metabotropic glutamate receptor signaling
|
Gan, Xiong |
|
2016 |
107 |
C |
p. 19-26 8 p. |
artikel |
30 |
RAAS inhibition and the course of Alport syndrome
|
Savva, Isavella |
|
2016 |
107 |
C |
p. 205-210 6 p. |
artikel |
31 |
Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticles
|
Gonzalez-Fajardo, Laura |
|
2016 |
107 |
C |
p. 93-101 9 p. |
artikel |
32 |
Relation among anti-rheumatic drug therapy, CD14+CD16+ blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study
|
Amoruso, Angela |
|
2016 |
107 |
C |
p. 308-314 7 p. |
artikel |
33 |
Restructuring of the extracellular matrix in diabetic wounds and healing: A perspective
|
Chang, Mayland |
|
2016 |
107 |
C |
p. 243-248 6 p. |
artikel |
34 |
Role of thromboxane-dependent platelet activation in venous thrombosis: Aspirin effects in mouse model
|
Tarantino, Eva |
|
2016 |
107 |
C |
p. 415-425 11 p. |
artikel |
35 |
Rosuvastatin: Beyond the cholesterol-lowering effect
|
Cortese, Francesca |
|
2016 |
107 |
C |
p. 1-18 18 p. |
artikel |
36 |
Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta
|
Ng, Hooi Hooi |
|
2016 |
107 |
C |
p. 220-228 9 p. |
artikel |
37 |
Sniping the scout: Targeting the key molecules in dendritic cell functions for treatment of autoimmune diseases
|
Li, Xing |
|
2016 |
107 |
C |
p. 27-41 15 p. |
artikel |
38 |
Sodium intake, RAAS-blockade and progressive renal disease
|
de Borst, Martin H. |
|
2016 |
107 |
C |
p. 344-351 8 p. |
artikel |
39 |
SRJ09, a promising anticancer drug lead: Elucidation of mechanisms of antiproliferative and apoptogenic effects and assessment of in vivo antitumor efficacy
|
Wong, Charng Choon |
|
2016 |
107 |
C |
p. 66-78 13 p. |
artikel |
40 |
SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing
|
Mavrou, Athina |
|
2016 |
107 |
C |
p. 276-281 6 p. |
artikel |
41 |
Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma
|
Smith, Lorey K. |
|
2016 |
107 |
C |
p. 42-47 6 p. |
artikel |
42 |
Targeting mutant NRAS signaling pathways in melanoma
|
Vu, Ha Linh |
|
2016 |
107 |
C |
p. 111-116 6 p. |
artikel |
43 |
The challenges of treating epilepsy with 25 antiepileptic drugs
|
Santulli, Lia |
|
2016 |
107 |
C |
p. 211-219 9 p. |
artikel |
44 |
The pharmacological management of psychiatric comorbidities in patients with epilepsy
|
Mula, Marco |
|
2016 |
107 |
C |
p. 147-153 7 p. |
artikel |
45 |
Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes
|
Massaro, Marika |
|
2016 |
107 |
C |
p. 125-136 12 p. |
artikel |
46 |
The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan
|
Arifa, Raquel Duque Nascimento |
|
2016 |
107 |
C |
p. 102-110 9 p. |
artikel |
47 |
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells
|
Montani, Maura |
|
2016 |
107 |
C |
p. 282-290 9 p. |
artikel |